Change Healthcare (CHNG) Peer Comparison

$27.49

$0.00 (0.00%)

As on 03-Oct-2022 09:30EDT

Market cap

$9,025 Mln

Revenue (TTM)

$3,497 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Edit

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Market cap ($ Mln)	9,025	732	4,621
Revenue ($ Mln)	3,497	1,176	235
Net Profit ($ Mln)	-76.95	37.29	-322.46
Net Margin (%)	-2.21	3.17	-151.76
RoE (%)	-2.35	31.69	-204.89
Price to Earnings	--	19.71	--
Price-To-Book	2.74	5.85	39.05

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Operating Revenue	3,480.82	1,120.49	194.75
Cost of Revenue	1,634.88	397.57	3.32
Gross Profit	3,480.82	722.91	191.43
Operating Expenses	3,344.00	127.75	479.12
Operating Profit (EBIT)	136.81	72.67	-287.69
Other Income	-8.57	--	-14.92
Profit before Tax	-106.00	43.14	-302.61
Provision for Tax	48.61	1.16	0.48
Profit after Tax (Net Income)	-57.39	41.98	-303.09
Minority Interest	--	--	--
Consolidated Profit	-57.39	41.98	-303.09

Liabilities ($ Mln)

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Shareholder's Funds	3,276.11	110.17	196.41
Minority Interest	--	--	--
Non-Current Liabilities	5,576.72	661.16	654.80
Current Liabilities	1,079.67	226.81	88.00
Total Liabilities	9,932.50	998.14	939.21

Assets ($ Mln)

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Non-Current Assets	8,619.59	679.81	137.24
Current Assets	1,312.91	318.33	801.97
Total Assets	9,932.50	998.14	939.21
Total Debt*	4,664.11	726.64	659.62
Net Current Assets	233.24	91.52	713.97

Cashflow ($ Mln)

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Cash From Operating Activities	696.88	36.21	-256.81
Cash Flow from Investing Activities	-276.94	-102.49	12.11
Cash from Financing Activities	-280.91	-16.63	434.34
Net Cash Inflow / Outflow	139.20	-82.91	189.63

Ratios

Profitability Ratios

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
ROCE (%)	-0.72	5.89	-42.51
ROE (%)	-1.76	52.10	-98.96
ROA (%)	-0.57	4.31	-36.45
EBIT Margin (%)	--	--	--
Net Margin (%)	-1.65	3.75	-168.55
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Revenue Growth (%)	0.13	0.12	0.57
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	48.85	9.92	-22.43
EPS Growth (%)	0.49	0.09	-0.19
Book Value Growth (%)	--	--	--

Valuation Ratios

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Price / Earnings	-123.07	16.90	-6.08
Price / Book Value	2.16	6.44	9.39
Dividend Yield (%)	--	--	--
EV/EBITDA	12.65	13.39	-6.53
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Debt to Equity	1.42	6.60	3.36
Short term debt to equity ratio	0.01	0.91	0.03
Current Ratio	1.22	1.40	9.11
Quick Ratio	--	1.02	8.45
Interest Coverage	0.96	2.49	-18.57

Operating Efficiency Ratios

	Change Healthcare (CHNG)	Hanger (HNGR)	Global Blood Therapeutics (GBT)
Debtors to sales (%)	20.69	13.57	14.79
Asset Turnover	0.35	1.15	0.23
Receivable days	83.19	48.83	43.42
Inventory Days	--	75.28	5,420.65
Payable days	18.07	59.10	1,882.15
Cash Conversion Cycle	--	65.02	3,581.91

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly